RFID in the Pharmaceutical Industry: Addressing Counterfeits with Technology

Journal of Medical Systems

Volumn 38, Issue 11, 2014, Pages

  Taylor, Douglas ^a  

^a The Medicine Group   (United States)

Author keywords

Counterfeit drugs; Radio frequency identification (RFID); Supply chain

Indexed keywords

COUNTERFEIT DRUG; HEPARIN; OLANZAPINE; OXYCODONE; SILDENAFIL;

ARTICLE; COMMERCIAL PHENOMENA; COMPUTER; COMPUTER PROGRAM; COST CONTROL; DRUG CONTROL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; EUROPE; HUMAN; INFORMATION PROCESSING; INFORMATION TECHNOLOGY; INVESTMENT; MICROPROCESSOR; NEGLIGENCE; RADIOFREQUENCY IDENTIFICATION; STRATEGIC PLANNING; UNITED KINGDOM; UNITED STATES; DEVICES; ORGANIZATION AND MANAGEMENT; RADIO FREQUENCY IDENTIFICATION DEVICE; SUPPLY AND DISTRIBUTION; UTILIZATION;

COUNTERFEIT DRUGS; DRUG INDUSTRY; EQUIPMENT AND SUPPLIES; RADIO FREQUENCY IDENTIFICATION DEVICE;

EID: 84919934109     PISSN: 01485598     EISSN: 1573689X     Source Type: Journal    
DOI: 10.1007/s10916-014-0141-y     Document Type: Article

References (23)

1. Blossom DB, Kallen AJ, Patel PR, Elward A, Robinson L, Gao G, et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359:2674–84.
2. Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy. 2007;60:214–36.
3. Rentz ED, Lewis L, Mujica OJ, Barr DB, Schier JG, Weerasekera G, et al. Outbreak of acute renal failure in Panama in 2006: a case–control study. Bull. World Health Organ. 2008;86:749–56.
4. Akinyandenu O. Counterfeit drugs in Nigeria: A threat to public health. African Medical Journal. 2013;7:2571–2516.
5. The Economist. Fake pharmaceuticals: Bad Medicine [Internet]. 2012 [cited 2014 Apr 17]. Available from: http://www.economist.com/node/21564546/
6. World Health Organization. Growing threat from counterfeit medicines. Bull. World Health Organ. 2010;88:247–8.
7. Lemonde-San F. Corporate Social Responsbility: Sanofi fights against counterfeit medicines. Sanofi; 2013 Jun.
8. Mackey TK, Liang BA. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism. BMC Medicine. BMC Medicine; 2013;11:233.
9. Shah N. Pharmaceutical supply chains: key issues and strategies for optimisation. Computers & Chemical Engineering. 2004;28:929–41.
10. Yong W, Andrechak G, Lou J, Riben M. A review of radio frequency identification technology for the anatomic pathology or biorepository laboratory: Much promise, some progress, and more work needed. J Pathol Inform. 2011;2:34.
11. Agrawal YK, Shah R, Prajapati P. Anticounterfeit packaging technologies. J Adv Pharm Tech Res. 2010;1:368.
12. Stanford V. Pervasive computing goes the last hundred feet with RFID systems. Pervasive Computing. 2003;2:9–14.
13. Attaran M. RFID: an enabler of supply chain operations. Supply Chain Management: An International Journal. 2007;12:249–57.
14. Collins J. Purdue Pharma tags OxyContin. RFID Journal. 2004; November.
15. Krivda C. RFID: After Compliance - Integration and Payback. Businessweek. 2004 Nov 30.
16. Yao W, Chu C-H, Li Z. The Adoption and Implementation of RFID Technologies in Healthcare: A Literature Review. J Med Syst. 2011;36:3507–25.
17. Reuters. Fake batches of Eli Lilly drug Zyprexa found in UK [Internet]. 2007 [cited 2014 Apr 25]. Available from: http://www.reuters.com/article/2007/05/25/idUSL2446370820070525
18. Japsen B. Baxter loses first Heparin case. Chicago Tribune [Internet]. Chicago; 2011 Jun 9. Available from: http://articles.chicagotribune.com/2011-06-09/business/chi-baxter-loses-first-heparin-case-20110609_1_baxter-heparin-animallike-substance-scientific-protein-laboratories
19. Howard JD. Implementation of RFID in the pharmaceutical industry. Singh J, editor. California Polytechnic State University; 2009.
20. Coustasse A, Tomblin S, Slack C. Impact of radio-frequency identification (RFID) technologies on the hospital supply chain: a literature review. Perspect Health Inf Manag. 2013;10:1d.
21. Christe B. Evaluation of current literature to determine the potential effects of radio frequency identification on technology used in diabetes care. J Diabetes Sci Technol. 2009;3:331–5.
22. Castro L, Lefebvre E, Lefebvre LA. Adding Intelligence to Mobile Asset Management in Hospitals: The True Value of RFID. J Med Syst. 2013;37:9963.
23. Sugita M, Miyakawa M. Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example. Environ Health Prev Med. 2010;15:244–51.